|
|
|
|
|
|
|
|
18.09.24 - 08:14
|
XFRA : 3AC: Wiederaufnahme/Resumption (XETRA)
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3
AB/FROM ONWARDS 18.09.2024...
|
|
|
|
16.09.24 - 08:14
|
XFRA : 3AC: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3 BAW/UFN...
|
|
|
26.08.24 - 04:49
|
Actinogen Medical′s Xanamem shows promising results in depression treatment trials (Small Caps)
|
|
Australian biotechnology company Actinogen Medical (ASX: ACW) has received further positive analysis from studies of its Xanamem treatment for symptoms of depression. The consistent benefits observed in the XanaCIDD phase 2a depression trial data support the conclusion that a 10 milligram Xanamem dose is clinically active in controlling brain cortisol and has clinically-significant anti-depressant activity. […]
The post Actinogen Medical's Xanamem shows promising results in depression treatment trials appeared first on Small Caps....
|
|
|
|
|
12.08.24 - 08:14
|
XFRA : 3AC: Wiederaufnahme/Resumption (XETRA)
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3
AB/FROM ONWARDS 12.08.2024...
|
|
|
08.08.24 - 08:08
|
XFRA : 3AC: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3 BAW/UFN...
|
|
|